Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hennessy

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|November 18, 2011
When should we believe nonrandomized studies of comparative effectiveness?S Hennessy
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 8, 2000
Potentially remediable features of the medication-use environment in the United StatesS Hennessy
Clinical Therapeutics|January 23, 1999
Postmarketing drug surveillance: an epidemiologic approachS Hennessy
Discharge Planning Update|June 7, 1993
Reemphasizing the tenets of managed careC Bush, S Hennessy
JAMA|April 20, 2001
Statins and fracture riskS Hennessy, B L Strom
Annals of Internal Medicine|February 26, 2000
Nonsedating antihistamines should be preferred over sedating antihistamines in patients who driveS Hennessy, B L Strom
Clinical Pharmacology and Therapeutics|April 20, 2012
The need for translational research on drug-drug interactionsS Hennessy, D A Flockhart
Foot & Ankle International|January 11, 2002
Traumatic 'mallet toe' of the hallux: a case reportM S Hennessy, T S Saxby
Clinical Pharmacology and Therapeutics|January 29, 2010
Assessing the safety and comparative effectiveness of follow-on biologics (biosimilars) in the United StatesS Hennessy, C E Leonard, R Platt
Irish Medical Journal|September 10, 2015
Temporal Trends in Hospitalisations for Heart FailureA Sugrue, Y Smyth, S Hennessy, et al.
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|November 18, 2011
When should we believe nonrandomized studies of comparative effectiveness?S Hennessy
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 8, 2000
Potentially remediable features of the medication-use environment in the United StatesS Hennessy
Clinical Therapeutics|January 23, 1999
Postmarketing drug surveillance: an epidemiologic approachS Hennessy
Discharge Planning Update|June 7, 1993
Reemphasizing the tenets of managed careC Bush, S Hennessy
JAMA|April 20, 2001
Statins and fracture riskS Hennessy, B L Strom
Annals of Internal Medicine|February 26, 2000
Nonsedating antihistamines should be preferred over sedating antihistamines in patients who driveS Hennessy, B L Strom
Clinical Pharmacology and Therapeutics|April 20, 2012
The need for translational research on drug-drug interactionsS Hennessy, D A Flockhart
Foot & Ankle International|January 11, 2002
Traumatic 'mallet toe' of the hallux: a case reportM S Hennessy, T S Saxby
Clinical Pharmacology and Therapeutics|January 29, 2010
Assessing the safety and comparative effectiveness of follow-on biologics (biosimilars) in the United StatesS Hennessy, C E Leonard, R Platt
Irish Medical Journal|September 10, 2015
Temporal Trends in Hospitalisations for Heart FailureA Sugrue, Y Smyth, S Hennessy, et al.
Pageof 8